A recent study demonstrated that liraglutide can alleviate liver fibrosis by inhibiting hepatocyte ferroptosis through upregulating SLC7A11 expression and the Nrf2/HO-1/GPX4 pathway (Song et al., 2022). This evidence concerns the gene GPX4 and Hepatic fibrosis.